Skip to main contentAI and Advanced
/
HAMPS · BSEBSE SENSEX74,314.59-0.03%BSE |
NIFTY 5023,270.6+0.23%NSE |
NIFTY BANK56,055.75-0.42%NSE |
NIFTY IT29,155.6+0.23%NSE |
NIFTY AUTO27,159.15+0.99%NSE |
NIFTY FMCG45,572.7+0.03%NSE |
NIFTY PHARMA26,579.25+1.66%NSE |
NIFTY 50022,654.65+0.54%NSE |
HA
BSE · Equity shares · Other Agricultural Products-2.55 · -10.00%
Hamps Bio Ltd HAMPS
NSE:Not available
BSE:INR 22.95
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsAvailable · provider snapshot
Research sections8 of 9 availableMissing source values remain unavailable, never zero-filled.
AI analysis and Advanced tools for HAMPS
Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 25.5
Day rangeINR 23.32 — INR 25.5
52-week rangeINR 20.7 — INR 26.58
Volume16,000
Market cap19.99
P/ENot available
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)4.53
Net Income (INR Cr)-0.46
EPS-0.53
Research path: Interpret Hamps Bio Ltd's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
HAMPSHamps Bio Ltd1d · INR · BSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
BSE reported results · INR crore
| Metric | Mar-26 | Sep-25 | FY25-26 |
|---|---|---|---|
| Revenue | 4.53 | 3.99 | 8.52 |
| Net Profit | -0.46 | -0.2 | -0.66 |
| EPS | -0.53 | -0.22 | -0.75 |
| Cash EPS | 0.06 | Not available | 0.18 |
| OPM % | 4.88 | 5.54 | 5.18 |
| NPM % | -10.14 | -4.91 | -7.69 |
Fundamentals
Valuation and ratios
Margins
Operating Margin 12m4.88
Net Profit Margin 12m-10.14
Valuation
Price to Sale Ratio4.41
Risk and consensus
Source-qualified signals
Risk metrics
Risk metrics unavailable.
Analyst consensus
Analyst consensus unavailable.
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
Peer data unavailable in the company profile payload.
Shareholding
Ownership
- Promoter and promoter group
- 71.99%
- Public shareholders
- 28.01%
- Other shareholders
- 0.00%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportBSE corporate filing · 11 Sept 2026, 5:30 am
Board Meeting Outcome for Board Meeting OutcomeBSE corporate filing · 9 Sept 2026, 5:30 am
Shareholder Meeting / Postal Ballot-Outcome of AGMBSE corporate filing · 9 Sept 2026, 5:30 am
Reg. 34 (1) Annual Report.BSE corporate filing · 17 Aug 2026, 5:30 am
Annual General Meeting To Be Held On Wednesday, September 9Th 2026BSE corporate filing · 17 Aug 2026, 5:30 am
Board Meeting Outcome for Board Meeting Outcome For Outcome Of Board Meeting Held On Wednesday, 12Th August 2026.BSE corporate filing · 12 Aug 2026, 5:30 am
Corporate actions
Events
- board MeetingsGeneral
- board MeetingsResults
- board MeetingsBonus
- board MeetingsIncrease in Authorised Capital
- board MeetingsResults
- board MeetingsResults
- corporate ActionsBonus issue 1:1
- board MeetingsGeneral
Rusaka Markets Community
Discussion and sentiment for Hamps Bio Ltd
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Checking your Rusaka Markets account…
Company profile
Business information
What the company does
Not available
Company facts
- Industry
- Other Agricultural Products
- Sector
- Fast Moving Consumer Goods
- Website
- www.hampsbio.com
- Address
- 2900/112, GIDC,, Near Atul Limited, Ankelshwar, Bharuch, Gujarat, 393002
- NSE Code
- HAMPS
- BSE Code
- 544312
- Listing date
- 20 Dec 2024
- Face value
- 10
- Market lot
- 4,000
- CIN
- L24233GJ2007PLC049692
- Company email
- info@hampsbio.com
- Company phone
- 8000006663
Leadership and officers
- Chairman and Managing Director
- Herrik Shah
- Whole-time Director
- Shrenik Shah
- Non-Executive Director
- Pallavi Shah
- Non- Executive Independent Director
- Jinay Palrecha
- Non - Executive Independent Director
- Ms. Shivali Rajpurohit
- Company Secretary & Compliance Officer
- Mr. Ravi Baheti
Questions
Stock FAQ
What is the symbol and ISIN of Hamps Bio Ltd?
Hamps Bio Ltd has the symbol HAMPS and ISIN - INE0QBD01018.
What is the current price of Hamps Bio Ltd?
Hamps Bio Ltd is currently trading at INR 22.95.
What are the year high and year low of Hamps Bio Ltd?
Hamps Bio Ltd has a year high of INR 26.58 and a year low of INR 20.70.
What is the market capitalization of Hamps Bio Ltd?
Hamps Bio Ltd has a market capitalization of INR 19.99 crore.
What is the P/E ratio of Hamps Bio Ltd?
Hamps Bio Ltd has a P/E ratio of NA.
What is the dividend yield of Hamps Bio Ltd?
Hamps Bio Ltd has a dividend yield of NA.
How is the financial performance of Hamps Bio Ltd based on revenue, net income, and EPS?
Hamps Bio Ltd has revenue of INR 4.53 crore, net income of INR -0.46 crore, and EPS of NA.
What is the book value of Hamps Bio Ltd?
Hamps Bio Ltd has a book value of NA.
What is the debt-to-equity ratio of Hamps Bio Ltd?
Hamps Bio Ltd has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of Hamps Bio Ltd?
Hamps Bio Ltd has a price-to-book ratio of NA and a price-to-sales ratio of 4.41.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.